Diligent Investors’s iShares Biotechnology ETF IBB Stock Holding History

Diligent Investors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,314	Closed	-$201K	–	279
2021 Q4	$201K	Buy	+1,314	New	+$203K	0.06%	253
2020 Q1	–	Sell	-1,801	Closed	-$217K	–	192
2019 Q4	$217K	Sell	1,801 -2,700	-60%	-$301K	0.1%	190
2019 Q3	$448K	Buy	4,501 +1,000	+29%	+$105K	0.22%	115
2019 Q2	$382K	Buy	3,501 +90	+3%	+$9.57K	0.19%	131
2019 Q1	$381K	Sell	3,411 -150	-4%	-$16.5K	0.22%	112
2018 Q4	$343K	Buy	3,561 +170	+5%	+$18K	0.23%	112
2018 Q3	$413K	Sell	3,391 -99	-3%	-$11.7K	0.23%	111
2018 Q2	$383K	Sell	3,490 -15	-0.4%	-$1.6K	0.23%	114
2018 Q1	$374K	Buy	3,505 +145	+4%	+$16.1K	0.23%	117
2017 Q4	$359K	Hold	3,360	–	–	0.23%	123
2017 Q3	$374K	Hold	3,360	–	–	0.27%	95
2017 Q2	$347K	Sell	3,360 -105	-3%	-$10.3K	0.25%	103
2017 Q1	$339K	Buy	3,465 +30	+0.9%	+$2.87K	0.26%	97
2016 Q4	$304K	Buy	3,435 +720	+27%	+$65.5K	0.24%	109
2016 Q3	$262K	Hold	2,715	–	–	0.21%	122
2016 Q2	$233K	Buy	+2,715	New	+$244K	0.22%	122

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Diligent Investors's IBB Position: Q1 2022 in Review

Diligent Investors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,314 shares — an estimated $201K sold.

Diligent Investors first reported a position in IBB in Q2 2016 and held it in 16 quarters. The position peaked at $448K in Q3 2019. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Diligent Investors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Diligent Investors sold 1,314 iShares Biotechnology ETF shares in Q1 2022, an estimated $201K.
Diligent Investors first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 16 quarters.
Diligent Investors's iShares Biotechnology ETF position peaked at $448K in Q3 2019.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Diligent Investors's 13F filing for Q1 2022, filed 26 Apr 2022.